"Our study findings underline the importance of informing a prostate cancer patient about the negative effects of smoking," says Shahrokh F. Shariat, Principal of the University Clinic of Urology at MedUni Vienna, who set up the ground-breaking study together with Malte Rieken, University Clinic of Urology at Basle University Hospital.
It makes sense for prostate cancer patients to quit smoking
However, according to the study findings, the negative impact of smoking on the risk of biochemical recurrence will have been offset within ten years of quitting. Hence, Shariat recommends: "It is never too late to quit smoking. On the contrary: as our study shows, it makes sense to quit, even if you are already suffering from prostate cancer."
International meta-study
The present study combined data from six international cancer research centers. The study population comprised 7,191 patients, who had had their prostate glands removed between 2000 – 2011 (radical prostatectomy; RP). None of the patients had received preoperative radiotherapy, hormonal therapy or chemotherapy. Patients with known metastasis at the time of diagnosis were excluded. Various statistical methods were used to analyze the data.
Link between smoking and the development of prostate cancer still uncertain
It is still not clear, in scientific terms, whether (and, if so, to what extent) smoking is associated with the development of prostate cancer. Older studies indicate that there is a clear association but recent studies show the opposite. However, what is proven is that smoking increases the risk of dying from prostate cancer. Shariat: “Many questions about prostate cancer and smoking are still unanswered. Further studies are therefore required to produce satisfactory answers."